# Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine

> **NCT02774395** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 40 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02774395
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02774395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02774395, "Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02774395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*